IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Vhcp Management, LLC

Q3 2014 Holdings

Filed 2014-11-13 | 21 holdings | $17.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
BioCryst Pharmaceuticals Inc(BCRX)COM09058V103$17.1M1,744,35698.8%
Avalanche Biotechnologies IncCOM05337G107$42.8K1,382,7350.2%
Anacor Pharmaceuticals IncCOM032420101$28.8K1,178,4740.2%
DBV TechnologiesCOMF2927N109$26.3K565,0000.2%
GW PharmaceuticalsCOM36197T103$25.2K311,8530.1%
Dyax CorpCOM26746E103$20.2K2,000,8590.1%
Radius Health IncCOM750469108$11.0K525,0000.1%
Zafgen IncCOM98885E103$10.0K541,4800.1%
Heron Therapeutics Inc(HRTX)COM427746102$9.1K1,095,7340.1%
Flamel Technologies S.A.COM338488109$7.2K500,0000.0%
Neurocrine Biosciences Inc(NBIX)COM64125C109$4.8K303,5030.0%
Lipocine IncCOM53630X104$4.1K669,9210.0%
TherapeuticsMD IncCOM88338N107$3.9K846,5000.0%
ZS Pharma IncCOM98979G105$3.9K100,0000.0%
OHR PharmaceuticalCOM67778H200$3.5K477,0000.0%
Ocera TherapeuticsCOM67552A108$3.4K703,7300.0%
Stemline Therapeutics IncCOM85858C107$88471,0000.0%
Alexza Pharmaceuticals IncCOM015384100$16671,2120.0%